Inside the lawsuit that ended US gene patenting
By Heidi Ledford,
Nature
| 10. 25. 2021
Not so long ago, if you asked someone about the US Patent and Trademark Office’s practice of granting patents on human genes, you’d probably get one of two responses. Biotechnology insiders would shrug — such patents had been standard practice for decades. They were considered a linchpin of the burgeoning genetic-testing industry. Those less intimate with the inner workings of biotech often had a different reaction: “But that’s just … wrong,” said lawyer Chris Hansen. “Who can we sue?”
In 2009, Hansen, a veteran of civil-rights cases at the American Civil Liberties Union (ACLU) in New York City, embarked on a lawsuit that ended gene patenting in the United States. The effort seemed doomed, yet Hansen went on to win at the US Supreme Court, challenging the very idea of what patents are and what they should do.
The unexpected twists and turns of that case — as well as its impact on medicine, and particularly on the lives of women affected by breast and ovarian cancer — are ably and affectingly detailed in The Genome Defense. Its author...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
